Synthesis and biological evaluation of substituted desloratadines as potent arginine vasopressin V2 receptor antagonists.

about

Controlled release strategy of paclitaxel by conjugating to matrix metalloproteinases-2 sensitive peptide.

P2860

Q37588432-CC29FFC3-3A1F-4251-B8DE-427183EB52BD

P2860

Synthesis and biological evaluation of substituted desloratadines as potent arginine vasopressin V2 receptor antagonists.

Item

http://www.wikidata.org/entity/Q39021158

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@en

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@nl

type

Item

label

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@en

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@nl

prefLabel

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@en

Synthesis and biological evalu ...... essin V2 receptor antagonists.

@nl

P1476

Synthesis and biological evalu ...... ressin V2 receptor antagonists

@en

P2093

Chang-Xiao Liu

http://www.w3.org/2001/XMLSchema#string

Deng-Ke Liu

http://www.w3.org/2001/XMLSchema#string

Min Gong

http://www.w3.org/2001/XMLSchema#string

Shuai Mu

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Novel treatment targets for cerebral edema

Nonpeptide arginine vasopressin antagonists for both V1A and V2 receptors: synthesis and pharmacological properties of 4-(1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine-6-carbonyl)benzanili de derivatives and 4'-(5,6-dihydro-4H-thiazolo[5,4-d][1]be

Involvement of the V2 receptor in vasopressin-stimulated translocation of placental leucine aminopeptidase/oxytocinase in renal cells

Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist.

Vasopressin V2 receptor antagonists.

Desloratadine: A new, nonsedating, oral antihistamine.

Diabetes diminishes the portal-systemic collateral vascular response to vasopressin via vasopressin receptor and Gα proteins regulations in cirrhotic rats.

Hyponatremia in heart failure: revisiting pathophysiology and therapeutic strategies.

Arginine vasopressin receptor antagonists (vaptans): pharmacological tools and potential therapeutic agents.

Significance of hyponatremia in heart failure.

P304

2694-2706

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MOLECULES19022694

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260378394

http://www.w3.org/2001/XMLSchema#string

P698

24566331

http://www.w3.org/2001/XMLSchema#string

P921

AVP

P932

6271649

http://www.w3.org/2001/XMLSchema#string

Synthesis and biological evaluation of substituted desloratadines as potent arginine vasopressin V2 receptor antagonists.

about

P2860

P2860

Synthesis and biological evaluation of substituted desloratadines as potent arginine vasopressin V2 receptor antagonists.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P921

P932